Indeed, tumor YAP expression is positively correlated with the survival rate of colon cancer patients, and epidermal growth factor receptor (EGFR)/YAP signaling plays a critical role in promoting 5-FU resistance [62]. This evidence concerns the gene YAP1 and colonic neoplasm.